PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
621.54%
Net income growth above 1.5x CRK's 192.34%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
9.06%
D&A growth well above CRK's 6.94%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
2081.16%
Well above CRK's 241.22% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
32.92%
Slight usage while CRK is negative at -378.10%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.92%
Growth of 32.92% while CRK is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
521.17%
Some yoy increase while CRK is negative at -156.42%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
185.43%
Operating cash flow growth above 1.5x CRK's 12.65%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-43.06%
Negative yoy CapEx while CRK is 44.40%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
275.76%
We have some outflow growth while CRK is negative at -8466.43%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
40.72%
Investing outflow well above CRK's 39.78%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-42.65%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-71.55%
Both yoy lines negative, with CRK at -75.32%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
99.51%
Buyback growth of 99.51% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.